The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has signed a Memorandum of Understanding (MoU) with Masdar City, Swiss company Xlife Sciences, and Thermo Fisher Scientific.
The agreement will see all parties working alongside DoH to enable and support innovation within Abu Dhabi’s healthcare sector, driving clinical research and clinical trial activities, and developing an eco-system to support the emirate’s life science startups.
This move is in line with the Department’s ongoing efforts to accelerate innovation in Abu Dhabi’s healthcare sector.
The MoU will allow innovators to test and further develop their solutions through extensive incubation to deliver market-ready offerings while leveraging the emirate’s advanced infrastructure for startups.
Further, all parties will work on driving research and form project groups that support evidence generation, thus improving the quality of clinical trials in Abu Dhabi.
In the presence of Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, and Ahmad Baghoum, CEO of Masdar City, the MoU was signed by Dr. Asma Ibrahim Al Mannaei, the Executive Director of the Research and Innovation Centre at DoH, Mohamed Al Breiki, Executive Director of Sustainable Development from Masdar City, Oliver R. Baumann Xlife Sciences CEO, and Sarah Chahine, Emerging Markets Sales Leader for Clinical Sequencing Division at Thermo Fisher Scientific.
On this occasion, Dr. Asma Ibrahim Al Mannaei said that, “We are delighted to be forging this strategic partnership with our partners from across the world to further strengthen our research capabilities and drive innovation in healthcare.”
“The Department of Health – Abu Dhabi (DoH) remains committed to providing the world with innovative solutions, evidence-based research, and supporting start-ups from ideation to commercialization. These collaborations further cement Abu Dhabi’s position as a leading destination for healthcare, a global life sciences hub, and an incubator for healthcare innovation,” Dr. Asma added.
